相似文献
1
Expression of beta-2-microglobulin by nasopharyngeal carcinoma.
Br J Cancer. 1992 Sep;66(3):555-7. doi: 10.1038/bjc.1992.313.
2
Beta-2-microglobulin (beta 2M) as a tumor marker in nasopharyngeal carcinoma.
Anticancer Res. 2000 Nov-Dec;20(6C):4765-8.
3
[Serum beta 2-microglobulin determination in nasopharyngeal carcinoma patients. An analysis of 139 cases].
Zhonghua Er Bi Yan Hou Ke Za Zhi. 1992;27(4):239-40, 256.
4
Serum levels of CYFRA 21-1 in nasopharyngeal carcinoma and its possible role in monitoring of therapy.
Eur J Cancer B Oral Oncol. 1996 Nov;32B(6):377-80. doi: 10.1016/s0964-1955(96)00017-6.
5
Serum beta-2-microglobulin in African Burkitt tumour, nasopharyngeal carcinoma and controls.
Biomedicine. 1981 Jul;35(3):104-7.
6
Strong association between hyperferritinaemia and metastatic disease in nasopharyngeal carcinoma.
Eur J Cancer B Oral Oncol. 1996 Jul;32B(4):242-5. doi: 10.1016/0964-1955(95)00084-4.
7
[Detection of bate 2-microglobulin fibronection and interleukin 2 content in patients with nasopharyngeal carcinoma].
Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2001 Nov;15(11):499-500.
8
Tissue polypeptide antigen (TPA) and beta 2-microglobulin (beta 2-MG) as tumour markers in nasopharyngeal cancer.
Ann Acad Med Singap. 1986 Oct;15(4):507-10.
9
Beta 2-microglobulin in squamous cell carcinomas of the head and neck and in tumours heterotransplanted into nude athymic mice.
Acta Otolaryngol. 1984 Sep-Oct;98(3-4):335-42. doi: 10.3109/00016488409107571.
10
Serum beta 2-microglobulin in malignant lymphoma.
Cancer. 1983 Jun 15;51(12):2220-5. doi: 10.1002/1097-0142(19830615)51:12<2220::aid-cncr2820511212>3.0.co;2-a.
本文引用的文献
1
Beta 2-microglobulin in squamous cell carcinomas of the head and neck and in tumours heterotransplanted into nude athymic mice.
Acta Otolaryngol. 1984 Sep-Oct;98(3-4):335-42. doi: 10.3109/00016488409107571.
2
Serum beta 2-microglobulin in patients with non-Hodgkin's lymphoma.
Eur J Cancer Clin Oncol. 1983 Mar;19(3):327-31. doi: 10.1016/0277-5379(83)90129-3.
3
Serum beta 2-microglobulin in malignant lymphoma.
Cancer. 1983 Jun 15;51(12):2220-5. doi: 10.1002/1097-0142(19830615)51:12<2220::aid-cncr2820511212>3.0.co;2-a.
4
Evaluation of serum beta 2-microglobulin as a prognostic indicator in myelomatosis.
Br J Cancer. 1983 Jan;47(1):111-4. doi: 10.1038/bjc.1983.13.
5
Beta-2 microglobulin--an immunogenetic marker of inflammatory and malignant origin.
Ann Clin Lab Sci. 1982 Nov-Dec;12(6):447-52.
6
beta 2-Microglobulin in clinical medicine.
Scand J Clin Lab Invest Suppl. 1980;154:27-37.
7
Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring.
Br J Cancer. 1980 Oct;42(4):510-5. doi: 10.1038/bjc.1980.273.
8
Serum beta 2-microglobulin in malignant and benign diseases of the stomach and pancreas.
Biomedicine. 1980 Jul-Aug;33(4):112-6.
9
Serum beta 2-microglobulin and C reactive protein concentrations in viral infections.
J Clin Pathol. 1984 Oct;37(10):1140-3. doi: 10.1136/jcp.37.10.1140.
10
Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active cases with long-term survivors.
J Natl Cancer Inst. 1973 Aug;51(2):361-9.
Zotero 插件